Home > Boards > Free Zone > User's Groups > $$$$$$$$ MICK, $Pistol Pete$ PINCHER CHART PLAYS $$$$$$$$

$CVSI BDS Analytics estimates that U.S. sales of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
Member Level 
Followed By 752
Posts 120,700
Boards Moderated 4
Alias Born 08/13/10
160x600 placeholder
U.S. Stocks Waver on Stimulus Talks, China's Growth
U.S. stocks wavered Monday as investors assessed the potential for a fresh stimulus package and China's economic recovery.
Bank of Canada Survey Find Business Sentiment Has Improved Over Summer, Outlook Uncertain
Verizon Buying Assets of Bluegrass Cellular in Kentucky
ConocoPhillips to Buy Shale Rival Concho for $9.7 Billion -- 3rd Update
China Adds New Export Restrictions in Latest Trade-Dispute Move -- Update
Bank of Canada Survey Find Business Sentiment Has Improved, Outlook Uncertain
Athene, MassMutual End $3 Billion Bid to Buy American Equity
AbbVie Seeks U.S., European OK of Rinvoq in Eczema
U.S. Home-Builder Confidence Continues to Rise in October to a New High
Form 8.3 -Willis Towers Watson Plc.
Holiday Crunch Starts Early With More Packages Than Means to Deliver Them
Correction to Holiday Package Delivery Article
Stock Futures Rise on Stimulus Talks, China's Growth
Where Trump and Biden Stand on International Accords and Alliances
Euro Optimism Wanes Amid Rising Covid-19 Cases
Top Company News of the Day
Eli Lilly: Health Canada Approves Taltz for Non-Radiographic Axial Spondyloarthritis
ConocoPhillips to Buy Shale Rival Concho for $9.7 Billion -- 2nd Update
China Adds New Export Restrictions in Latest Trade-Dispute Move
CVS to Hire 15,000 Employees in the U.S. in 4Q
Naturgy Wins Bunkering LNG Contract in Spain
Alibaba Takes on Walmart in China With $3.6 Billion Investment in Hypermarket Chain
ConocoPhillips to Buy Concho Resources in $9.7 Billion All-Stock Transaction
Bristol Myers Squibb, Exelixis Get Priority Review for Kidney-Cancer Treatment
SpotOnTrade Member Level  Saturday, 02/15/20 02:32:48 PM
Re: Hunchbackgeek post# 635
Post # of 640 
$CVSI BDS Analytics estimates that U.S. sales of cannabis and hemp-derived CBD product is expected to surge from $1.9 billion in 2018 to $20 billion by 2024, a compound annual growth rate of 49%. According to their research, there is substantial consumer interest in the consumables (tinctures, pills, beverages, food) and Topicals (creams, balms, salves) formats, despite the current low consumer penetration rate. In addition, many major national retailers (CVS, Walgreens, Rite Aid, Sprouts, Whole Foods, Ulta, GNC Holdings, Designer Brands, Urban Outfitters, and Neiman Marcus) have been early adopters of CBD topical products and have introduced various product lines in select markets.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences